MCUJF
Medicure Inc.
Price Chart
Latest Quote
$2.97
-0.08 (-2.62%)
Current Price
| Previous Close | $3.05 |
| Open | $2.91 |
| Day High | $3.00 |
| Day Low | $2.91 |
| Volume | 12,004 |
Stock Information
Note: Financial values converted from CAD to USD
| Shares Outstanding | 10.44M |
| Total Debt | $499K |
| Cash Equivalents | $1.31M |
| Revenue | $22.99M |
| Net Income | $-5.34M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $33.28M |
| EPS (TTM) | $-0.53 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $29.87M |
| Sales | $22.99M |
| Income | $-5.34M |
| Book/sh | $0.79 |
| Cash/sh | $0.18 |
Financial Ratios
| Quick Ratio | 0.61 |
| Current Ratio | 0.97 |
| Debt/Eq | 6.01 |
Returns & Margins
| ROA | -17.78% |
| ROE | -49.88% |
| Gross Margin | 38.00% |
| Operating Margin | -18.22% |
| Profit Margin | -23.23% |
Ownership
| Insider Ownership | 27.30% |
| Institutional Ownership | 23.10% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 4.57 |
| P/S | 1.04 |
| P/B | 3.76 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.84 |
| SMA50 | $2.23 |
| SMA200 | $1.17 |
| RSI | 60.61 |
| ATR | 0.1807 |
| Shares Float | 5.22M |
| Short Ratio | 1.85 |
| Volatility | 1.21 |
| Rel Volume | 0.78 |
Performance History
| Week | -2.62% |
| Month | +44.88% |
| Quarter | +233.71% |
| 6 Months | +296.00% |
| YTD | +271.25% |
| Year | +219.35% |
| 3 Years | +175.00% |
| 5 Years | +271.25% |
| 10 Years | -27.74% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-11-03 | $2.97 | 16,300 |
| 2026-11-02 | $3.05 | 53,600 |
| 2026-10-30 | $3.13 | 58,100 |
| 2026-10-29 | $3.09 | 3,800 |
| 2026-10-28 | $3.09 | 13,500 |
| 2026-10-27 | $3.05 | 6,900 |
| 2026-10-26 | $3.15 | 18,500 |
| 2026-10-23 | $3.00 | 15,400 |
| 2026-10-22 | $3.08 | 15,500 |
| 2026-10-21 | $3.13 | 600 |
| 2026-10-20 | $3.11 | 21,100 |
| 2026-10-19 | $3.10 | 11,400 |
| 2026-10-16 | $2.98 | 52,000 |
| 2026-10-15 | $2.94 | 7,800 |
| 2026-10-14 | $2.76 | 44,500 |
| 2026-10-13 | $2.80 | 74,300 |
| 2026-10-12 | $2.10 | 0 |
| 2026-10-09 | $2.10 | 2,900 |
| 2026-10-08 | $2.10 | 3,100 |
| 2026-10-07 | $2.07 | 0 |
| 2026-10-06 | $2.07 | 4,300 |
| 2026-10-05 | $2.05 | 6,100 |
About Medicure Inc.
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order, and online pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.
đ° Latest News
No news articles available at the moment. Check back later for updates on MCUJF.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $8,818,000 | $7,705,000 | $6,990,000 | $9,032,000 |
| Cost Of Revenue | $8,818,000 | $7,705,000 | $6,990,000 | $9,032,000 |
| Total Revenue | $21,907,000 | $21,694,000 | $23,065,000 | $21,744,000 |
| Operating Revenue | $21,907,000 | $21,694,000 | $23,065,000 | $21,744,000 |
| Expenses | ||||
| Interest Expense | $10,000 | $20,000 | $-23,000 | $38,000 |
| Total Expenses | $24,644,000 | $22,548,000 | $21,872,000 | $23,837,000 |
| Other Income Expense | $1,789,000 | $-108,000 | $354,000 | $1,585,000 |
| Other Non Operating Income Expenses | $1,860,000 | - | $346,000 | $1,828,000 |
| Net Non Operating Interest Income Expense | $165,000 | $65,000 | $-162,000 | $-251,000 |
| Total Other Finance Cost | $31,000 | $-10,000 | $195,000 | $291,000 |
| Interest Expense Non Operating | $10,000 | $20,000 | $-23,000 | $38,000 |
| Operating Expense | $15,826,000 | $14,843,000 | $14,882,000 | $14,805,000 |
| Selling And Marketing Expense | $7,981,000 | $8,306,000 | $7,935,000 | $10,312,000 |
| General And Administrative Expense | $4,764,000 | $4,131,000 | $4,193,000 | $2,697,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-1,039,000 | $-922,000 | $1,365,000 | $-727,000 |
| Net Interest Income | $165,000 | $65,000 | $-162,000 | $-251,000 |
| Interest Income | $206,000 | $75,000 | $33,000 | $78,000 |
| Normalized Income | $-978,650 | $-857,200 | $1,357,116 | $-494,245 |
| Net Income From Continuing And Discontinued Operation | $-1,039,000 | $-922,000 | $1,365,000 | $-727,000 |
| Net Income Common Stockholders | $-1,039,000 | $-922,000 | $1,365,000 | $-727,000 |
| Net Income | $-1,039,000 | $-922,000 | $1,365,000 | $-727,000 |
| Net Income Including Noncontrolling Interests | $-1,039,000 | $-922,000 | $1,365,000 | $-727,000 |
| Net Income Continuous Operations | $-1,039,000 | $-922,000 | $1,365,000 | $-727,000 |
| Pretax Income | $-783,000 | $-897,000 | $1,385,000 | $-759,000 |
| Special Income Charges | $0 | $0 | $-44,000 | $-274,000 |
| Interest Income Non Operating | $206,000 | $75,000 | $33,000 | $78,000 |
| Operating Income | $-2,737,000 | $-854,000 | $1,193,000 | $-2,093,000 |
| Gross Profit | $13,089,000 | $13,989,000 | $16,075,000 | $12,712,000 |
| Per Share | ||||
| Diluted EPS | $-0.10 | $-0.09 | $0.13 | $-0.07 |
| Basic EPS | $-0.10 | $-0.09 | $0.13 | $-0.07 |
| Other | ||||
| Tax Effect Of Unusual Items | $-10,650 | $-43,200 | $116 | $-10,245 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,612,000 | $1,401,000 | $3,240,000 | $2,667,000 |
| Total Unusual Items | $-71,000 | $-108,000 | $8,000 | $-243,000 |
| Total Unusual Items Excluding Goodwill | $-71,000 | $-108,000 | $8,000 | $-243,000 |
| Reconciled Depreciation | $2,314,000 | $2,170,000 | $2,055,000 | $3,145,000 |
| EBITDA (Bullshit earnings) | $1,541,000 | $1,293,000 | $3,248,000 | $2,424,000 |
| EBIT | $-773,000 | $-877,000 | $1,193,000 | $-721,000 |
| Diluted Average Shares | $10,436,313 | $10,244,444 | $10,436,313 | $10,251,313 |
| Basic Average Shares | $10,436,313 | $10,244,444 | $10,251,313 | $10,251,313 |
| Diluted NI Availto Com Stockholders | $-1,039,000 | $-922,000 | $1,365,000 | $-727,000 |
| Tax Provision | $256,000 | $25,000 | $20,000 | $-32,000 |
| Restructuring And Mergern Acquisition | $0 | $0 | $44,000 | $274,000 |
| Gain On Sale Of Security | $-71,000 | $-108,000 | $52,000 | $31,000 |
| Research And Development | $3,081,000 | $2,406,000 | $2,754,000 | $1,796,000 |
| Selling General And Administration | $12,745,000 | $12,437,000 | $12,128,000 | $13,009,000 |
| Other Gand A | $4,764,000 | $4,131,000 | $4,193,000 | $2,697,000 |
| Impairment Of Capital Assets | - | - | - | $0 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $8,049,000 | $7,854,000 | $7,204,000 | $4,225,000 |
| Total Assets | $29,679,000 | $28,059,000 | $29,898,000 | $28,408,000 |
| Total Non Current Assets | $13,782,000 | $12,853,000 | $15,051,000 | $15,854,000 |
| Other Non Current Assets | $98,000 | $75,000 | $63,000 | $57,000 |
| Goodwill And Other Intangible Assets | $12,729,000 | $12,042,000 | $13,801,000 | $14,186,000 |
| Other Intangible Assets | $9,354,000 | $8,940,000 | $10,624,000 | $11,212,000 |
| Current Assets | $15,897,000 | $15,206,000 | $14,847,000 | $12,554,000 |
| Prepaid Assets | $126,000 | $1,143,000 | $1,134,000 | $869,000 |
| Inventory | $3,282,000 | $2,900,000 | $3,221,000 | $3,329,000 |
| Receivables | $5,298,000 | $4,794,000 | $5,635,000 | $4,659,000 |
| Other Receivables | $35,000 | $368,000 | $110,000 | $66,000 |
| Accounts Receivable | $5,263,000 | $4,426,000 | $5,525,000 | $4,593,000 |
| Cash Cash Equivalents And Short Term Investments | $7,191,000 | $6,369,000 | $4,857,000 | $3,694,000 |
| Cash And Cash Equivalents | $7,191,000 | $6,369,000 | $4,857,000 | $3,694,000 |
| Restricted Cash | - | - | $0 | $3,000 |
| Debt | ||||
| Total Debt | $874,000 | $544,000 | $849,000 | $1,169,000 |
| Long Term Debt And Capital Lease Obligation | $506,000 | $229,000 | $503,000 | $789,000 |
| Current Debt And Capital Lease Obligation | $368,000 | $315,000 | $346,000 | $380,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,901,000 | $8,163,000 | $8,893,000 | $9,997,000 |
| Total Non Current Liabilities Net Minority Interest | $506,000 | $229,000 | $503,000 | $1,485,000 |
| Current Liabilities | $8,395,000 | $7,934,000 | $8,390,000 | $8,512,000 |
| Payables And Accrued Expenses | $8,027,000 | $7,619,000 | $7,865,000 | $7,416,000 |
| Payables | $8,027,000 | $7,619,000 | $7,865,000 | $7,416,000 |
| Total Tax Payable | $95,000 | $16,000 | $60,000 | $114,000 |
| Income Tax Payable | $95,000 | $16,000 | $60,000 | $114,000 |
| Accounts Payable | $7,932,000 | $7,603,000 | $7,128,000 | $6,668,000 |
| Tradeand Other Payables Non Current | - | - | $0 | $591,000 |
| Other Current Liabilities | - | - | $179,000 | $716,000 |
| Other Payable | - | - | $677,000 | $634,000 |
| Other Non Current Liabilities | - | - | - | $105,000 |
| Equity | ||||
| Common Stock Equity | $20,778,000 | $19,896,000 | $21,005,000 | $18,411,000 |
| Total Equity Gross Minority Interest | $20,778,000 | $19,896,000 | $21,005,000 | $18,411,000 |
| Stockholders Equity | $20,778,000 | $19,896,000 | $21,005,000 | $18,411,000 |
| Gains Losses Not Affecting Retained Earnings | $-4,264,000 | $-5,989,000 | $-5,458,000 | $-6,640,000 |
| Other Equity Adjustments | $-4,264,000 | $-5,989,000 | $-5,458,000 | $-6,640,000 |
| Retained Earnings | $-66,891,000 | $-65,852,000 | $-64,930,000 | $-66,295,000 |
| Other | ||||
| Ordinary Shares Number | $10,436,313 | $10,436,313 | $10,251,313 | $10,251,313 |
| Share Issued | $10,436,313 | $10,436,313 | $10,251,313 | $10,251,313 |
| Tangible Book Value | $8,049,000 | $7,854,000 | $7,204,000 | $4,225,000 |
| Invested Capital | $20,778,000 | $19,896,000 | $21,005,000 | $18,411,000 |
| Working Capital | $7,502,000 | $7,272,000 | $6,457,000 | $4,042,000 |
| Capital Lease Obligations | $874,000 | $544,000 | $849,000 | $1,169,000 |
| Total Capitalization | $20,778,000 | $19,896,000 | $21,005,000 | $18,411,000 |
| Additional Paid In Capital | $10,919,000 | $10,723,000 | $10,476,000 | $10,429,000 |
| Capital Stock | $81,014,000 | $81,014,000 | $80,917,000 | $80,917,000 |
| Common Stock | $81,014,000 | $81,014,000 | $80,917,000 | $80,917,000 |
| Long Term Capital Lease Obligation | $506,000 | $229,000 | $503,000 | $789,000 |
| Current Capital Lease Obligation | $368,000 | $315,000 | $346,000 | $380,000 |
| Goodwill | $3,375,000 | $3,102,000 | $3,177,000 | $2,974,000 |
| Net PPE | $955,000 | $736,000 | $1,187,000 | $1,611,000 |
| Accumulated Depreciation | $-2,798,000 | $-2,295,000 | $-1,874,000 | $-1,387,000 |
| Gross PPE | $3,753,000 | $3,031,000 | $3,061,000 | $2,998,000 |
| Leases | $183,000 | $182,000 | $183,000 | $182,000 |
| Other Properties | $2,583,000 | $1,915,000 | $1,930,000 | $1,907,000 |
| Machinery Furniture Equipment | $987,000 | $934,000 | $948,000 | $909,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $2,849,000 | $2,354,000 | $2,632,000 | $2,611,000 |
| Work In Process | $433,000 | $546,000 | $589,000 | $718,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $638,000 | $1,809,000 | $1,518,000 | $3,171,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,377,000 | $2,079,000 | $1,828,000 | $3,989,000 |
| Cash Flow From Continuing Operating Activities | $1,377,000 | $2,079,000 | $1,844,000 | $3,989,000 |
| Operating Gains Losses | $71,000 | $108,000 | $-52,000 | $-31,000 |
| Investing Activities | ||||
| Capital Expenditure | $-739,000 | $-270,000 | $-310,000 | $-818,000 |
| Investing Cash Flow | $-739,000 | $-270,000 | $-310,000 | $-2,694,000 |
| Cash Flow From Continuing Investing Activities | $-739,000 | $-270,000 | $-310,000 | $-2,694,000 |
| Net Other Investing Changes | - | - | - | $-1,876,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-370,000 | $-297,000 | $-355,000 | $-316,000 |
| Cash Flow From Continuing Financing Activities | $-370,000 | $-297,000 | $-355,000 | $-316,000 |
| Repurchase Of Capital Stock | - | - | $0 | $0 |
| Net Common Stock Issuance | - | - | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-370,000 | $-353,000 | $-355,000 | $-316,000 |
| End Cash Position | $7,191,000 | $6,369,000 | $4,857,000 | $3,694,000 |
| Beginning Cash Position | $6,369,000 | $4,857,000 | $3,694,000 | $2,716,000 |
| Effect Of Exchange Rate Changes | $554,000 | $0 | $0 | $-1,000 |
| Changes In Cash | $268,000 | $1,512,000 | $1,163,000 | $979,000 |
| Proceeds From Stock Option Exercised | $0 | $56,000 | $0 | $0 |
| Net Issuance Payments Of Debt | $-370,000 | $-353,000 | $-355,000 | $-316,000 |
| Net Long Term Debt Issuance | $-370,000 | $-353,000 | $-355,000 | $-316,000 |
| Long Term Debt Payments | $-370,000 | $-353,000 | $-355,000 | $-316,000 |
| Net Intangibles Purchase And Sale | $-739,000 | $-270,000 | $-296,000 | $-441,000 |
| Purchase Of Intangibles | $-739,000 | $-270,000 | $-296,000 | $-441,000 |
| Net PPE Purchase And Sale | $0 | $0 | $-14,000 | $-377,000 |
| Purchase Of PPE | $0 | $0 | $-14,000 | $-377,000 |
| Taxes Refund Paid | $-177,000 | $-61,000 | $-91,000 | $0 |
| Interest Received Cfo | $175,000 | $48,000 | $-16,000 | $49,000 |
| Change In Working Capital | $-332,000 | $467,000 | $-326,000 | $1,488,000 |
| Change In Other Current Assets | $-18,000 | $0 | $-2,000 | $99,000 |
| Change In Payables And Accrued Expense | $-494,000 | $-236,000 | $568,000 | $20,000 |
| Change In Prepaid Assets | $237,000 | $-26,000 | $-194,000 | $305,000 |
| Change In Inventory | $-207,000 | $-31,000 | $166,000 | $471,000 |
| Change In Receivables | $150,000 | $760,000 | $-864,000 | $593,000 |
| Changes In Account Receivables | $150,000 | $760,000 | $-864,000 | $593,000 |
| Other Non Cash Items | $-165,000 | $-321,000 | $-1,212,000 | $-1,377,000 |
| Stock Based Compensation | $196,000 | $288,000 | $47,000 | $135,000 |
| Asset Impairment Charge | $78,000 | $277,000 | $38,000 | $1,339,000 |
| Deferred Tax | $256,000 | $25,000 | $20,000 | $-32,000 |
| Deferred Income Tax | $256,000 | $25,000 | $20,000 | $-32,000 |
| Depreciation Amortization Depletion | $2,314,000 | $2,170,000 | $2,055,000 | $3,145,000 |
| Depreciation And Amortization | $2,314,000 | $2,170,000 | $2,055,000 | $3,145,000 |
| Amortization Cash Flow | $1,876,000 | $1,736,000 | $1,594,000 | $2,739,000 |
| Amortization Of Intangibles | $1,876,000 | $1,736,000 | $1,594,000 | $2,739,000 |
| Depreciation | $438,000 | $434,000 | $461,000 | $406,000 |
| Net Foreign Currency Exchange Gain Loss | $71,000 | $108,000 | $-52,000 | $-31,000 |
| Net Income From Continuing Operations | $-1,039,000 | $-922,000 | $1,365,000 | $-727,000 |
| Net Business Purchase And Sale | - | $0 | $0 | $-1,876,000 |
| Purchase Of Business | - | $0 | $0 | $-1,876,000 |
| Common Stock Payments | - | - | $0 | $0 |
| Interest Paid Cfo | - | - | $-16,000 | - |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Sale Of Investment | - | - | - | $0 |
| Purchase Of Investment | - | - | - | $0 |
Fetched: 2026-02-02